Efficacy and safety of dulaglutide in the treatment of type 2 diabetes: a comprehensive review of the dulaglutide clinical data focusing on the AWARD phase 3 clinical trial program.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Efficacy and safety of dulaglutide in the treatment of type 2 diabetes: a comprehensive review of the dulaglutide clinical data focusing on the AWARD phase 3 clinical trial program.
- Published In:
- Diabetes/metabolism research and reviews, 32(8), 776-790 (2016)
- Authors:
- Jendle, Johan, Grunberger, George, Blevins, Thomas, Giorgino, Francesco, Hietpas, Ryan T, Botros, Fady T
- Database ID:
- RPEP-02978
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-02978APA
Jendle, Johan; Grunberger, George; Blevins, Thomas; Giorgino, Francesco; Hietpas, Ryan T; Botros, Fady T. (2016). Efficacy and safety of dulaglutide in the treatment of type 2 diabetes: a comprehensive review of the dulaglutide clinical data focusing on the AWARD phase 3 clinical trial program.. Diabetes/metabolism research and reviews, 32(8), 776-790. https://doi.org/10.1002/dmrr.2810
MLA
Jendle, Johan, et al. "Efficacy and safety of dulaglutide in the treatment of type 2 diabetes: a comprehensive review of the dulaglutide clinical data focusing on the AWARD phase 3 clinical trial program.." Diabetes/metabolism research and reviews, 2016. https://doi.org/10.1002/dmrr.2810
RethinkPeptides
RethinkPeptides Research Database. "Efficacy and safety of dulaglutide in the treatment of type ..." RPEP-02978. Retrieved from https://rethinkpeptides.com/research/jendle-2016-efficacy-and-safety-of
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.